Estimation of a disease progression model for COPD using data from the ECLIPSE study

M. Tabberer, A. Exuzides, C. Colby, A. Briggs, D. Lomas, M. Rutten van-Molken, M. Chambers, H. Muellerova, N. Locantore, N. Risebrough, S. Gonzalez-McQuire (Research Triangle Park, San Francisco, United States Of America; Glasgow, London, Uxbridge, United Kingdom; Rotterdam, Netherlands; Toronto, Canada)

Source: Annual Congress 2013 –Health economics of airway diseases
Session: Health economics of airway diseases
Session type: Poster Discussion
Number: 282
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Tabberer, A. Exuzides, C. Colby, A. Briggs, D. Lomas, M. Rutten van-Molken, M. Chambers, H. Muellerova, N. Locantore, N. Risebrough, S. Gonzalez-McQuire (Research Triangle Park, San Francisco, United States Of America; Glasgow, London, Uxbridge, United Kingdom; Rotterdam, Netherlands; Toronto, Canada). Estimation of a disease progression model for COPD using data from the ECLIPSE study. Eur Respir J 2013; 42: Suppl. 57, 282

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Measurement properties of exacerbations of chronic pulmonary disease tool (EXACT) in a clinical trial of patients with moderate to severe COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013


Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)
Source: Eur Respir J 2008; 31: 869-873
Year: 2008



Evaluation of asthma/COPD overlap within the ECLIPSE study
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


Risk scores for predicting death in COPD patients
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016


The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013

Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Agreement of severity stages and exacerbations building the new COPD risk groups
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013


Exercise related desaturation in patients with COPD – Another step towards phenotyping the disease
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013


Predictor parameters for exercise intolerance in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

Predictive accuracy of a simple functional index in chronic obstructive pulmonary disease
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015


Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014


Determinants of severity of dyspnea in COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015

Anemia in COPD patients of Korean obstructive lung disease (KOLD) cohort
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015

COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015